Renal oncocytoma screening: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
m Bot: Removing from Primary care |
||
| (One intermediate revision by one other user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{Homa}} {{SC}} | {{CMG}}; {{AE}}{{Homa}} {{SC}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for renal oncocytoma. | |||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine [[screening]] for renal oncocytoma. | |||
==References== | ==References== | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
| Line 44: | Line 15: | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
Latest revision as of 23:57, 29 July 2020
|
Renal oncocytoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal oncocytoma screening On the Web |
|
American Roentgen Ray Society Images of Renal oncocytoma screening |
|
Risk calculators and risk factors for Renal oncocytoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]
Overview
There is insufficient evidence to recommend routine screening for renal oncocytoma.
Screening
There is insufficient evidence to recommend routine screening for renal oncocytoma.